It may appear complex and driven by technical
language. At its heart, however, it asks a simple question: in the circumstance of this patient what is the right thing to do? An approach based on the key ethical principles provides a structure in the decision-making process around the appropriateness of dialysis; in this way ethics can lead to better and more nuanced decision-making. Several guidelines on the initiation of and withdrawal from dialysis provide assistance in these deliberations, including the (USA) RPA guidelines and to a lesser extent the CARI guidelines. Each of the bioethical principles is important. Autonomy does not override the other principles. All clinicians, including Nephrologists, have a responsibility to carefully balance the benefits and burdens
of treatment, including dialysis, and communicate that recommendation to the patient and family. The wishes and values of a patient should NVP-LDE225 mw be considered but they should not, taken alone, be determinative. This issue arises when a patient or family wants treatment that is not felt Roxadustat molecular weight to be appropriate by the nephrologist. In difficult cases Nephrologists should seek the advice and formal opinion of colleagues and, where available, a Bioethicist. This is particularly useful when conflict arises within families about which treatment pathway should be adopted. Advance care planning is a process of patient-centred discussion, ideally involving family/significant others, to assist the patient to understand how their illness might affect them, identify their goals and establish how medical treatment might help them to achieve these. An individual must be competent to make decisions about their healthcare in order to participate in Advance Care Planning. Advance Care Planning discussions may result in the formulation ZD1839 nmr of an Advance Care Plan which articulates the individual’s wishes, preferences, values and goals relevant to their current and future health care.
An Advance Care Plan is only one useful outcome from the Advance Care Planning process, the education of patient and family around prognosis and treatment options is likely to be beneficial whether or not a plan is written or the individual loses decision-making capacity at the end of life. Advance care planning should be available to all patients with CKD, including ESKD on renal replacement therapy. Such plans need to be reviewed regularly as patients’ circumstances may change. Advance care planning provides benefits to patients as their end of life wishes are more likely to be known and followed when individuals have been through the Advance Care Planning process; feelings of isolation and lack of hope may be experienced when individuals are not able to honestly and openly discuss their hopes and fears for the future with loved ones. Having Advance care discussions does not result in loss of hope for patients.